Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, 29 March 2019 - NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced an increase of the number of shares and votes in NeuroVive of 22,594,467 as a result of a fully performed preferential rights issue, resolved by the Board of Directors on 10 December 2018 and approved at the Extraordinary General Meeting on 17 January 2019, and a conducted directed new issue of shares on 7 March 2019.Today, the last trading day of the month, there are in total 185,952,591 shares and votes in NeuroVive Pharmaceutical AB. This information is information that